ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 126 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $300 | -19.8% | 100 | 0.0% | 0.00% | – |
| Q2 2023 | $374 | +11.6% | 100 | 0.0% | 0.00% | – |
| Q1 2023 | $335 | -30.4% | 100 | 0.0% | 0.00% | – |
| Q4 2022 | $481 | -51.9% | 100 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,000 | -83.3% | 100 | -39.4% | 0.00% | -75.0% |
| Q3 2021 | $6,000 | – | 165 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $22,222,000 | 1.76% |
| EcoR1 Capital, LLC | 5,376,134 | $48,063,000 | 1.53% |
| Cormorant Asset Management, LP | 1,679,442 | $15,014,000 | 0.89% |
| CM Management, LLC | 100,000 | $894,000 | 0.68% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 596,800 | $5,335,000 | 0.40% |
| PDT Partners, LLC | 278,487 | $2,490,000 | 0.19% |
| Ikarian Capital, LLC | 116,600 | $1,043,000 | 0.16% |
| HighVista Strategies LLC | 20,659 | $185,000 | 0.15% |
| Aristides Capital LLC | 35,132 | $314,000 | 0.14% |
| Parkwood LLC | 71,932 | $643,000 | 0.11% |